RECRUITINGOBSERVATIONAL
D-SOLVE Cohorts (Cohort a and B)
About This Trial
Hepatitis D is by far the most severe form of chronic viral hepatitis, frequently leading to liver failure, hepatocellular carcinoma and death. Hepatitis D is caused by coinfection Hepatitis D is caused by co-infection with hepatitis B virus (HBV) and hepatitis D virus (HDV). This multicenter cohort should enable a comprehensive and unbiased biomarker screening of well-defined HDV-infected patients, followed by mechanistic studies to determine the functional role of distinct molecules. Patient surveillance strategies and antiviral treatment approaches could be personalized which should reduce clinical and social disease burden, improve quality of life and save direct and indirect costs caused by HDV infection.
Who May Be Eligible (Plain English)
Who May Qualify:
- Anti-HDV positive
- ≥18 years old
- Sex: m/f/d
- willing to sign a consent form for prospective procedures
Who Should NOT Join This Trial:
- Anti-HDV negative
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Anti-HDV positive
* ≥18 years old
* Sex: m/f/d
* Informed consent for prospective procedures
Exclusion Criteria:
* Anti-HDV negative
Locations (4)
Hannover Medical School, Department of Gastroenterology, Hepatology, Infectious Disease and Endocrinology
Hanover, Germany
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (University of Milan)
Milan, Italy
Institutul de Boli Infectioase "Prof. Dr. Matei Bals"
Bucharest, Romania
Karolinska University Hospital and Karolinska Institutet
Stockholm, Sweden